CAS 1366302-52-4

PSMA-11

CAS: 1366302-52-4

PSMA-11 tracer detects prostate cancer by binding to PSMA; used in PET scans for tumor localization with gallium Ga 68 labeling.

Formel: C₄₄H₆₂N₆O₁₇

Reinheit: 99.59%

Farbe und Form: Solid

Molekulargewicht: 946.99

Ref: TM-T28466

PSMA-11

CAS: 1366302-52-4

PSMA-11

Reinheit: ≥98%

Molekulargewicht: 946.99g/mol

Ref: 54-BUP00955

PSMA-11

CAS: 1366302-52-4

Formel: C₄₄H₆₂N₆O₁₇

Molekulargewicht: 947.01

Ref: 4Z-PP-392001

PSMA-11

CAS: 1366302-52-4

PSMA-11 is a positron-emitting metal chelate that is used in the diagnosis of prostate cancer. It is administered as a diagnostic agent and has been shown to be clinically relevant for prostate cancer diagnosis. PSMA-11 has shown to have pharmacokinetic properties that can be retrospectively analyzed by measuring the amount of radioactivity in the patient's urine, which is indicative of the amount of PSMA-11 absorbed by the body. This biomarker can also be used for assessing the effectiveness of radiation therapy in patients with prostate cancer. PSMA-11 has been shown to bind to the human serum albumin, which may contribute to its pharmacokinetic properties. The imaging properties of PSMA-11 are still being explored but it has been found to show promise for use as a diagnostic agent in early stages of prostate cancer.

Formel: C₄₄H₆₂N₆O₁₇

Reinheit: Min. 95%

Farbe und Form: Powder

Molekulargewicht: 947 g/mol

Ref: 3D-REC30252

PSMA-11

Kontrolliertes Produkt

CAS: 1366302-52-4

Formel: C₄₄H₆₂N₆O₁₇

Farbe und Form: Neat

Molekulargewicht: 946.993

Ref: TR-C136660